Prognosis in inflammatory arthritis: The value of HLA genotyping and the oncological analogy

Journal of Rheumatology

Volumn 24, Issue 7, 1997, Pages 1436-1442

  Emery, Paul ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRITIS; CONFERENCE PAPER; DIAGNOSTIC VALUE; GENOTYPE; HLA SYSTEM; INFLAMMATORY DISEASE; ONCOLOGY; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROGNOSIS; ARTICLE; GENETICS; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; METHODOLOGY; PREDICTION AND FORECASTING; RHEUMATOID ARTHRITIS; RHEUMATOLOGY;

BIOLOGICAL MARKER;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; GENOTYPE; HISTOCOMPATIBILITY TESTING; HUMANS; MEDICAL ONCOLOGY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RHEUMATOLOGY;

EID: 0031181315     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Pincus T, Callahan LF: Remodelling the pyramid or remodelling the paradigms concerning rheumatoid arthritis: Lessons from Hodgkin's disease and coronary artery disease. J Rheumatol 1990;17:1582-5.
2. McIntosh E: Clinical audit - the cost of rheumatoid arthritis. Br J Rheumatol 1996;35:781-90.
3. Rasker JJ, Cosh JA: Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis. Ann Rheum Dis 1981;40:115-20.
4. Gough AK, Lilley J, Eyre S, et al: Generalised bone loss in patients with early rheumatoid arthritis occurs early and relates to disease activity. Lancer 1994;344:23-7.
5. van Leeuwen MA, van Rijswijk MH, van der Heijde DMFM, et al: The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: A prospective study during the first three years of the disease. Br J Rheumatol 1993;(suppl 3)32:3-8.
6. Rasker JJ, Cosh JA: The natural history of rheumatoid arthritis. A fifteen year follow-up study. The prognostic significance of features noted in the first year. Clin Rheumatol 1984;1:11-20.
7. Devlin J, Gough AK, Huissoon A, et al: The acute phase and function in early rheumatoid arthritis. CRP levels correlate with functional outcome. J Rheumatol 1997;24:9-13.
8. Emery P: The optimal management of early rheumatoid arthritis: The key to preventing disability. Br J Rheumatol 1994;33:765-8.
9. Tunn EJ, Bacon PA: Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol 1990;32:97.
10. Devlin J, Gough AK, Huissoon A, et al: Knee disease in 766 early arthritis patients, relevance to outcome and pathogenesis (abstr). Arthritis Rheum 1993;(suppl 41)36:5262.
11. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Green M, Proudman S, Richardson C, et al: Prognostic markers determining persistence of disease in very early mild inflammatory arthritis patients post-treatment with depomedrone (abstr). Br J Rheumatol 1997;(suppl 1)36:294.
13. Emery P, Symmons PM: What is early rheumatoid arthritis?: Definition and diagnosis. Baillieres Clin Rheumatol 1997;11:13-26.
14. Proudman SM, Richardson C, Green MJ, et al: Treatment of poor prognosis early rheumatoid arthritis: Randomised study of conventional therapy with sulphasalazine vs aggressive therapy with methotrexate, cyclosporin and intra-articular corticosteroids (abstr). Br J Rheumatol 1997;(suppl 1)36:104.
15. Boers M, Verhoeven AC, Markusse HM, et al: Combination of step-down prednisolone, methotrexate and sulphasalazine, compared to sulphasalazine alone in early rheumatoid arthritis: Excellent disease control and low toxicity in the COBRA randomised trial. Lancet (in press).
16. van der Heijde DMFM, van Riel PLCM, van der Putte LBA: Influence of prognostic features on final outcome in rheumatoid arthritis: A review of the literature. Semin Arthritis Rheum 1988;17:284-92.
17. Bywaters EGL, Curwen M, Dresner E, et al: Ten-year follow-up of rheumatoid arthritis. Lancet 1960;2:1381.
18. Brennan P, Harrison B, Barrett E, et al: A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid disease: Prospective cohort study. BMJ 1996;313:471-6.
19. van der Heijde DM, van Riel PL, van Leeuwen MA, et al: Older vs younger onset rheumatoid arthritis: Results at onset and after two years of a prospective follow-up study of early rheumatoid arthritis. J Rheumatol 1995;18:1285-9.
20. Terkteltaub R, Esdaile J, Décary F, et al: A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. J Rheumatol 1983;10:418-24.
21. Fleming A, Crown JM, Corbett M: Prognostic value of early features in rheumatoid disease. BMJ 1976;1:1243-5.
22. Otten HA, Westendrop Boerma F: Significance of the Waaler-Rose test, streptococcal agglutination, and antistreptolysin titer in the prognosis of rheumatoid arthritis. Ann Rheum Dis 1959;18:24-8.
23. van Jaarsveld CHM, van der Heide A, Jacobs JWG, et al: Rheumatoid arthritis should be treated early with slow acting antirheumatic drugs (abstr). Br J Rheumatol 1997;(suppl 1)36:104.
24. Tsakonas E, Fitzgerald A, Fitzcharles MA, et al: Preliminary results of a prospective long-term study of the effects of early institution of DMARD therapy in rheumatoid arthritis (abstr). J Rheumatol 1997;24:1424.
25. Jacoby RK, Jayson MIV, Cosh JA: Onset, early stages, and prognosis of rheumatoid arthritis: A clinical study of 100 patients with 11-year follow-up. BMJ 1973;2:96-100.
26. Scott DL, Coulton BL, Symmons DPM, et al: Long-term outcome of treating rheumatoid arthritis: Results after 20 years. Lancet 1987;1:1108-11.
27. van Zeben D, Hazes JMW, Zwinderman AH, et al: Clinical significance of rheumatoid factors in early rheumatoid arthritis: Results of a follow-up study. Ann Rheum Dis 1992;51:1029-35.
28. Panayi GS, Celinska E, Emery P, et al: Seronegative and seropositive rheumatoid arthritis and similar diseases. Br J Rheumatol 1987;12:172-80.
29. Cook AD, Rowley MJ, MacKay IR, Gough A, Emery P: Antibodies to type II collagen in early rheumatoid arthritis: Correlation with disease progression. Arthritis Rheum 1996;39:1720-7.
30. Cordonnier C, Meyer O, Palazzo E, et al: Diagnostic value of anti-Ra33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: Comparison with rheumatoid factor. Br J Rheumatol 1996;35:620-4.
31. Young A, Smuar N, Bodman K, et al: Agalactosyl IgG: An aid to differential diagnosis in early synovitis. Arthritis Rheum 1991;34:1425-9.
32. Emery P, Bradley H, Arthur V, et al: Increased prevalence of poor sulphoxidation in patients with rheumatoid arthritis. Ann Rheum Dis 1991;51:318-20.
33. Jaraquemada D, Ollier W, Awad J, et al: HLA and rheumatoid arthritis: A combined analysis of 440 British patients. Ann Rheum Dis 1986;45:627-36.
34. Gregersen PK, Shen M, Song QL, et al: Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci USA 1986;83:2642-6.
35. Wordsworth P, Bell JI: The immunogenetics of rheumatoid arthritis. Curr Opin Rheumatol 1990;2:423-9.
36. Ollier WER, Stephens CS, Awood J, et al: Is rheumatoid arthritis in Indians associated with HLA antigens sharing a DRB1 epitope? Ann Rheum Dis 1991;50:295-7.
37. Wordsworth BP, Salmon M: Bailliere's Clin Rheumatol 1992;6:325-36.
38. van Leeuwen MA, Westra J, van Riel PLCM, et al: IgM, IgA and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression? Scand J Rheumatol 1995;24:146-53.
39. Gough AK, Faint MJ, Salmon M, et al: Genetic typing of patients with inflammatory arthritis at presentation is predictive of outcome. Arthritis Rheum 1994;37:1166-70.
40. van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, et al: Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 1992; 31:519-25.
41. Young A, Corbett M, Winfield J, et al: A prognostic index for erosive changes in the hands, feet, and cervical spines in early rheumatoid arthritis. Br J Rheumatol 1988;27:94-101.
42. Emery P, Salmon M, Bradley H, et al: Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis. BMJ 1992;305:1387-9.
43. van Zeben D, Hazes JMW, Zwinderman H, et al: Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a follow-up group. Arthritis Rheum 1991;24:822-30.
44. van Zeben D, Hazes JMW, Zwinderman H, et al: Factors predicting outcome of rheumatoid arthritis: Results of a follow-up study. J Rheumatol 1993;20:1288-96.
45. Griffiths B, Situnayaka RD, Salmon M, et al: A matched cross-sectional study of the shared epitope and disease severity in North Indians and Pakistanis compared with Northern European RA patients (abstr). Arthritis Rheum 1996;3 (suppl)39:S153.
46. O'Dell J, Nepom B, Haire C, et al: DRB1 typing in rheumatoid arthritis is useful in predicting response to specific therapy (abstr). Arthritis Rheum 1996;(suppl)39:S305.
47. McGonagle D, Green MJ, Proudman S, et al: The majority of patients with rheumatoid arthritis have erosive disease at presentation when magnetic resonance imaging of the dominant hand is employed (abstr). Br J Rheumatol 1997;(suppl 1)36:121.